...September 1, 2023 Teleflex Inc.'s second-quarter results reflect solid business fundamentals and improving operating conditions. In the second quarter ended July 2, 2023, the company's revenue grew 5.5% (5.9% on a constant currency basis) compared with the same period in 2022, reflecting growth in most of the company's business segments. However, the Interventional Urology and Anesthesia segment posted a low-single-digit percent decline in revenue in the quarter due to slower-than-expected recovery in some procedures and tougher comparisons in 2022. The performance led the company to increase its 2023 constant currency revenue growth guidance to 5.50%-6.25% from 5.0%-6.25% and reported (GAAP) growth guidance to 5.80%-6.55% from 4.65%-5.90% previously. The company's revenue growth is supported by its considerable portfolio breadth that covers multiple therapeutical areas, strong market positions of its "durable growth" portfolio, and its innovative products within the `high-growth" portfolio...
